Zeo ScientifiXZEOX +7.34%52 Days Inventory is 103.05 as of Apr. 2026, which is 16% below its 10-year median of 122.33. GuruFocus rates ZEOX with a GF Score™ of 52/100 and a GF Value™ of $2.67 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 638 Biotechnology companies, Zeo ScientifiX ranks better than 66.61% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Zeo ScientifiX's Average Total Inventories for the
three
months ended in Apr. 2026 was $0.59 Mil. Zeo ScientifiX's Cost of Goods Sold for the
three
months ended in Apr. 2026 was $0.53 Mil.
Hence, Zeo ScientifiX's Days Inventory for the
three
months ended in Apr. 2026 was 103.05.
The historical rank and industry rank for Zeo ScientifiX's Days Inventory or its related term are showing as below:
ZEOX'
s Days Inventory Range Over the Past 10 Years
Min: 38.42 Med: 122.33 Max: 208.57
Current: 118.97
During the past 13 years, Zeo ScientifiX's highest Days Inventory was 208.57. The lowest was 38.42. And the median was 122.33.
ZEOX's Days Inventory is ranked better than 66.61% of 638
companies
in the Biotechnology industry
Industry Median: 183.875
vs ZEOX: 118.97
Zeo ScientifiX's Days Inventory
increased
from Apr. 2025 (85.55) to Apr. 2026 (103.05).
It might indicate that Zeo ScientifiX's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Zeo ScientifiX's Inventory Turnover for the
three
months ended in Apr. 2026 was 0.89.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zeo ScientifiX's Inventory-to-Revenue for the
three
months ended in Apr. 2026 was 0.23.
Zeo ScientifiX (OTCPK:ZEOX) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Zeo ScientifiX's Inventory Turnover for the
three
months ended in Apr. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zeo ScientifiX's Inventory to Revenue for the
three
months ended in Apr. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Zeo ScientifiX Days Inventory Related Terms
Zeo ScientifiX Days Inventory Historical Data
* Premium members only.
The historical data trend for Zeo ScientifiX's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ZEOX vs JUNS, HOOK, LEXX: Days Inventory Comparison
For the Biotechnology subindustry, Zeo ScientifiX's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zeo ScientifiX Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's Days Inventory distribution charts can be found below:
* The bar in red indicates where Zeo ScientifiX's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zeo ScientifiX (ZEOX) has a Days Inventory of 103.05 as of Apr. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zeo ScientifiX and its competitors. This is 16% below median its historical median of 122.33. Over the past decade, Zeo ScientifiX's Days Inventory has ranged from 38.42 to 208.57. According to the industry distribution chart, Zeo ScientifiX ranks #213 out of 638 companies in the Biotechnology industry, placing it in the top 33.4%.
Is Zeo ScientifiX's Days Inventory too high?
Zeo ScientifiX's current Days Inventory of 103.05 is 16% below median its 10-year median of 122.33. Over the past 10 years, this metric has ranged from a low of 38.42 to a high of 208.57. The Biotechnology industry median Days Inventory is 183.88. Zeo ScientifiX's value of 103.05 is 44% below this industry median. Based on the distribution chart, Zeo ScientifiX ranks #213 out of 638 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Zeo ScientifiX has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zeo ScientifiX's Days Inventory compare to JUNS and HOOK?
According to the Biotechnology industry distribution chart, Zeo ScientifiX ranks #213 out of 638 companies for Days Inventory. This puts Zeo ScientifiX in the upper half of its industry. The industry median Days Inventory is 183.88. Zeo ScientifiX's value of 103.05 is 44% below this benchmark. Historically, Zeo ScientifiX's own Days Inventory has ranged from 38.42 to 208.57 over the past decade. While the company's 10-year median is 122.33 vs. the industry median of 183.88, Zeo ScientifiX has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zeo ScientifiX's current Days Inventory of 103.05 is 44% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zeo ScientifiX and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zeo ScientifiX's current Days Inventory is 103.05, which is 16% below median its own 10-year median of 122.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeo ScientifiX stock overvalued right now?
Based on GuruFocus' analysis, Zeo ScientifiX (ZEOX) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.67, compared to a current price of $1.90 — trading 28.8% below its estimated fair value. The current Days Inventory is 103.05, which is 16% below median its 10-year median of 122.33 and 44% below the Biotechnology industry median of 183.88. Zeo ScientifiX's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Zeo ScientifiX (ZEOX), the current Days Inventory is 103.05 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zeo ScientifiX (ZEOX) Overvalued in 2026?
Based on GuruFocus' analysis, Zeo ScientifiX stock appears to be undervalued.
The current stock price of $1.90 is trading 28.8% below its estimated GF Value™ of $2.67.
GuruFocus considers Zeo ScientifiX to be Modestly Undervalued.
Key valuation signals for ZEOX:
Days Inventory: 103.05 (16% below median its 10-year median of 122.33)
GF Value™: $2.67 vs. price of $1.90 (28.8% below fair value)
Industry Position: 44% below the Biotechnology median (#213 of 638)
No single metric tells the full story. See the ZEOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).
52GF Score
Get the complete analysis for ZEOX
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZEOX has been successfully added to your 
